A Study to Evaluate the Efficacy and Safety of Etanercept and Adalimumab in Children aged 2 to 4 years With Juvenile Idiopathic Arthritis (JIA): A BIKER registry study.
Phase of Trial: Phase IV
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 25 Apr 2017 New trial record